Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venovenous extracorporeal membrane oxygenation support in patients with COVID-19 respiratory failure: A multicenter study.

JTCVS open·2022
Same author

Alternative Input for Perfusion Management Devices: Voice Recognition for Data Input and the Effects on Charting and Perioperative Calculation Use.

The journal of extra-corporeal technology·2022
Same author

Simultaneous quantification of cyclosporin, tacrolimus, sirolimus and everolimus in whole blood by UHPLC-MS/MS for therapeutic drug monitoring.

Biomedical chromatography : BMC·2021
Same author

Quantification of mycophenolic acid in human plasma by liquid chromatography with time-of-flight mass spectrometry for therapeutic drug monitoring.

Biomedical chromatography : BMC·2020
Same author

Perfusion Recruitment Strategies Using Choice-Based Conjoint Analysis.

The journal of extra-corporeal technology·2020
Same author

Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane oxygenation.

Journal of cardiac surgery·2020

Related Experiment Video

Updated: Jul 2, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Does zero balance ultrafiltration decrease the incidence of post-cardiopulmonary bypass atrial fibrillation?

Mark T Lucas1, John Limoli, Joseph Schlut

  • 1Department of Surgery, Centura St. Anthony Central Hospital, Denver, Colorado, USA. mlucas56@hotmail.com

The Journal of Extra-Corporeal Technology
|August 19, 2008
PubMed
Summary
This summary is machine-generated.

Postoperative atrial fibrillation (Afib) is common after cardiac surgery. This study found that while zero balance ultrafiltration (ZBUF) did not reduce Afib incidence, older age and female gender significantly increase Afib risk.

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Experiment Videos

Last Updated: Jul 2, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Critical Care Medicine

Background:

  • Postoperative atrial fibrillation (Afib) is a frequent complication following cardiac surgery, increasing risks of stroke, heart failure, and prolonged hospitalization.
  • Cardiac surgery with cardiopulmonary bypass (CPB) triggers a systemic inflammatory response syndrome (SIRS), contributing to arrhythmias.
  • Zero balance ultrafiltration (ZBUF) is hypothesized to mitigate SIRS by removing inflammatory mediators.

Purpose of the Study:

  • To investigate if zero balance ultrafiltration (ZBUF) reduces the incidence of postoperative atrial fibrillation (Afib) after cardiopulmonary bypass (CPB).

Main Methods:

  • A retrospective analysis of consecutive primary coronary artery bypass patients who underwent CPB between January 2004 and June 2006.
  • Data collected included patient demographics, Afib occurrence, ZBUF use, blood product administration, surgical times, comorbidities, and postoperative outcomes.
  • Univariate analysis was performed to identify factors associated with Afib, with a p-value threshold of .05.

Main Results:

  • New onset Afib occurred in 27% of patients.
  • Older age (odds ratio 1.078 per unit increase) and female gender (odds ratio 2.629) were significantly associated with an increased risk of Afib.
  • The study did not statistically prove the hypothesis that ZBUF reduces Afib incidence.

Conclusions:

  • Older age and female gender are significant risk factors for developing postoperative atrial fibrillation after cardiac surgery.
  • Further research is needed to confirm the efficacy of ZBUF in preventing Afib or to explore other preventative strategies.